- Home
- UEIC vs GALT Comparison
UEIC vs GALT Comparison
Compare UEIC & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UEIC
- GALT
- Stock Information
- Founded
- UEIC 1986
- GALT 2000
- Country
- UEIC United States
- GALT United States
- Employees
- UEIC N/A
- GALT N/A
- Industry
- UEIC Consumer Electronics/Appliances
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- UEIC Consumer Staples
- GALT Health Care
- Exchange
- UEIC Nasdaq
- GALT Nasdaq
- Market Cap
- UEIC 150.4M
- GALT 147.8M
- IPO Year
- UEIC 1993
- GALT N/A
- Fundamental
- Price
- UEIC $11.52
- GALT $2.12
- Analyst Decision
- UEIC Strong Buy
- GALT Strong Buy
- Analyst Count
- UEIC 2
- GALT 1
- Target Price
- UEIC $14.50
- GALT $11.00
- AVG Volume (30 Days)
- UEIC 55.9K
- GALT 549.5K
- Earning Date
- UEIC 02-13-2025
- GALT 11-13-2024
- Dividend Yield
- UEIC N/A
- GALT N/A
- EPS Growth
- UEIC N/A
- GALT N/A
- EPS
- UEIC N/A
- GALT N/A
- Revenue
- UEIC $382,019,000.00
- GALT N/A
- Revenue This Year
- UEIC N/A
- GALT N/A
- Revenue Next Year
- UEIC $5.38
- GALT N/A
- P/E Ratio
- UEIC N/A
- GALT N/A
- Revenue Growth
- UEIC N/A
- GALT N/A
- 52 Week Low
- UEIC $7.53
- GALT $1.56
- 52 Week High
- UEIC $14.20
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- UEIC 56.37
- GALT 39.78
- Support Level
- UEIC $11.33
- GALT $1.80
- Resistance Level
- UEIC $12.50
- GALT $2.36
- Average True Range (ATR)
- UEIC 0.45
- GALT 0.23
- MACD
- UEIC -0.14
- GALT -0.03
- Stochastic Oscillator
- UEIC 21.60
- GALT 26.89
About UEIC Universal Electronics Inc.
Universal Electronics Inc is a United States-based company that principally designs, develops, manufactures, ships, and supports control and sensor technology solutions and a broad line of universal control systems, audio-video (AV) accessories, wireless security, and smart home products that are used by the world's brands in the video services, consumer electronics, security, home automation, climate control and home appliance markets. It generates its total revenue from the United States.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.